Halder Venture Approves Auditor Changes, Capital Increase, and Warrant Issue
Halder Venture Limited's board approved the appointment of M/s J Kumar Jain & Associates as Internal Auditors. They also consented to increase authorized share capital from ₹13.42 crore to ₹18.42 crore and approved the issue of 7,93,650 warrants at ₹315 each, convertible into equity shares, to specified persons like P.K. Bio Link Private Limited.
The increase in authorized share capital and the proposed issuance of warrants indicate potential future fundraising and expansion activities. These actions can impact the company's capital structure and ownership, warranting a medium impact assessment.
The announcement details several corporate actions including auditor changes, capital increase, and warrant issuance, which are standard business procedures. While these are significant, they do not inherently indicate a positive or negative shift in the company's immediate performance or outlook.
Halder Venture Limited announced key decisions made during its Board Meeting on March 26, 2026. The board accepted the resignation of M/s Somnath Ray & Associates as Internal Auditors, citing preoccupation. Subsequently, M/s J Kumar Jain & Associates were appointed as the new Internal Auditors for the Financial Year 2025-2026.
The company also received board consent to increase its authorized share capital from ₹13.42 crore to ₹18.42 crore, involving the creation of an additional 50 lakh equity shares of ₹10 each. This change is subject to shareholder approval via postal ballot.
Furthermore, the board approved the creation, issue, and offer of 7,93,650 convertible warrants, each with a face value of ₹10, at a price of ₹315 per warrant. These warrants are convertible into one fully paid-up equity share and will be offered to specified persons, including P.K. Bio Link Private Limited, which is proposed to be allotted 7,93,650 warrants for ₹24,99,99,750. This issuance is also subject to shareholder approval through postal ballot.
The company will seek shareholder consent for these proposals via a postal ballot notice.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under auditor changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.